176 related articles for article (PubMed ID: 9109450)
21. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
22. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
23. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
24. Manipulation of immune regulation in systemic lupus erythematosus.
La Cava A; Fang CJ; Singh RP; Ebling F; Hahn BH
Autoimmun Rev; 2005 Nov; 4(8):515-9. PubMed ID: 16214088
[TBL] [Abstract][Full Text] [Related]
25. [Immunology in medical practice. III. Disseminated lupus erythematosus: disturbed apoptosis?].
Berden JH
Ned Tijdschr Geneeskd; 1997 Sep; 141(39):1848-54. PubMed ID: 9545742
[TBL] [Abstract][Full Text] [Related]
26. A viral DNA-binding domain elicits anti-DNA antibodies of different specificities.
Cerutti ML; Zarebski LM; de Prat Gay G; Goldbaum FA
Mol Immunol; 2005 Feb; 42(3):327-33. PubMed ID: 15589321
[TBL] [Abstract][Full Text] [Related]
27. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
28. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones.
Moens U; Seternes OM; Hey AW; Silsand Y; Traavik T; Johansen B; Rekvig OP
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12393-7. PubMed ID: 8618908
[TBL] [Abstract][Full Text] [Related]
29. The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen.
Spanielová H; Velková K
Acta Virol; 2001 Jun; 45(3):191-5. PubMed ID: 11774899
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
31. Binding of nuclear proteins to the negative regulatory element of the IL-2 gene in lymphocytes from rheumatic patients.
Flescher E; Vela-Roch N; Talal N; Dang H
Cytokine; 1999 Mar; 11(3):187-91. PubMed ID: 10209065
[TBL] [Abstract][Full Text] [Related]
32. Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: clues to their origin.
Sharma A; Isenberg DA; Diamond B
J Autoimmun; 2001 Jun; 16(4):479-84. PubMed ID: 11437497
[TBL] [Abstract][Full Text] [Related]
33. Induction of anti-DNA antibodies by immunization with activated lymphocytes and active chromatin.
Lu L; Li J; Wang M; Wu H
Chin Med J (Engl); 1998 Jun; 111(6):524-6. PubMed ID: 11245072
[TBL] [Abstract][Full Text] [Related]
34. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
35. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
[TBL] [Abstract][Full Text] [Related]
36. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
37. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
[TBL] [Abstract][Full Text] [Related]
38. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.
Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Garcea RL; Woodland RT; Welsh RM
Virology; 2001 Feb; 280(2):160-8. PubMed ID: 11162830
[TBL] [Abstract][Full Text] [Related]
39. Distinct amounts of polyomavirus large T antigen are required for different functions of the protein.
Ogris E; Mudrak I; Wintersberger E
Oncogene; 1993 May; 8(5):1277-83. PubMed ID: 8386826
[TBL] [Abstract][Full Text] [Related]
40. [T- and B-lymphocytes in the so-called collagenoses].
Standhofer M; Fritz J; Grond K; Klein G
Z Rheumatol; 1975; 34(11-12):418-24. PubMed ID: 1082214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
